Richard A. Flavell

Richard A. Flavell

Yale University

H-index: 275

North America-United States

Professor Information

University

Yale University

Position

Sterling Professor of Immunobiology HHMI Investigator

Citations(all)

285005

Citations(since 2020)

68563

Cited By

242138

hIndex(all)

275

hIndex(since 2020)

132

i10Index(all)

1220

i10Index(since 2020)

818

Email

University Profile Page

Yale University

Research & Interests List

Immunology

Top articles of Richard A. Flavell

Genetically modified non-human animals expressing human epo

Genetically modified non-human animals expressing human EPO from the animal genome are provided. Also provided are methods for making non-human animals expressing human EPO from the non-human animal genome, and methods for using non-human animals expressing human EPO from the non-human animal genome. These animals and methods find many uses in the art, including, for example, in modeling human erythropoiesis and erythrocyte function; in modeling human pathogen infection of erythrocytes; in in vivo screens for agents that modulate erythropoiesis and/or erythrocyte function, eg in a healthy or a diseased state; in in vivo screens for agents that are toxic to erythrocytes or erythrocyte progenitors; in in vivo screens for agents that prevent against, mitigate, or reverse the toxic effects of toxic agents on erythrocytes or erythrocyte progenitors; in in vivo screens of erythrocytes or erythrocyte …

Published Date

2023/9/26

DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestinal stem cells

Epithelial barrier dysfunction and crypt destruction are hallmarks of inflammatory bowel disease (IBD). Intestinal stem cells (ISCs) residing in the crypts play a crucial role in the continuous self-renewal and rapid recovery of intestinal epithelial cells (IECs). However, how ISCs are dysregulated in IBD remains poorly understood. Here, we observe reduced DHX9 protein levels in IBD patients, and mice with conditional DHX9 depletion in the intestinal epithelium (Dhx9ΔIEC) exhibit an increased susceptibility to experimental colitis. Notably, Dhx9ΔIEC mice display a significant reduction in the numbers of ISCs and Paneth cells. Further investigation using ISC-specific or Paneth cell-specific Dhx9-deficient mice demonstrates the involvement of ISC-expressed DHX9 in maintaining epithelial homeostasis. Mechanistically, DHX9 deficiency leads to abnormal R-loop accumulation, resulting in genomic instability and the …

Authors

Xingxing Ren,Qiuyuan Liu,Peirong Zhou,Tingyue Zhou,Decai Wang,Qiao Mei,Richard A Flavell,Zhanju Liu,Mingsong Li,Wen Pan,Shu Zhu

Journal

Nature Communications

Published Date

2024/4/9

IL-10 constrains sphingolipid metabolism to limit inflammation.

Interleukin-10 (IL-10) is a key anti-inflammatory cytokine that can limit immune cell activation and cytokine production in innate immune cell types. Loss of IL-10 signalling results in life-threatening inflammatory bowel disease in humans and mice—however, the exact mechanism by which IL-10 signalling subdues inflammation remains unclear, , –. Here we find that increased saturated very long chain (VLC) ceramides are critical for the heightened inflammatory gene expression that is a hallmark of IL-10 deficiency. Accordingly, genetic deletion of ceramide synthase 2 (encoded by Cers2), the enzyme responsible for VLC ceramide production, limited the exacerbated inflammatory gene expression programme associated with IL-10 deficiency both in vitro and in vivo. The accumulation of saturated VLC ceramides was regulated by a decrease in metabolic flux through the de novo mono-unsaturated fatty acid synthesis …

Authors

Autumn G York,Mathias H Skadow,Joonseok Oh,Rihao Qu,Quan D Zhou,Wei-Yuan Hsieh,Walter K Mowel,J Richard Brewer,Eleanna Kaffe,Kevin J Williams,Yuval Kluger,Stephen T Smale,Jason M Crawford,Steven J Bensinger,Richard A Flavell

Journal

Nature

Published Date

2024/2/21

Gene trajectory inference for single-cell data by optimal transport metrics

Single-cell RNA sequencing has been widely used to investigate cell state transitions and gene dynamics of biological processes. Current strategies to infer the sequential dynamics of genes in a process typically rely on constructing cell pseudotime through cell trajectory inference. However, the presence of concurrent gene processes in the same group of cells and technical noise can obscure the true progression of the processes studied. To address this challenge, we present GeneTrajectory, an approach that identifies trajectories of genes rather than trajectories of cells. Specifically, optimal transport distances are calculated between gene distributions across the cell–cell graph to extract gene programs and define their gene pseudotemporal order. Here we demonstrate that GeneTrajectory accurately extracts progressive gene dynamics in myeloid lineage maturation. Moreover, we show that GeneTrajectory …

Authors

Rihao Qu,Xiuyuan Cheng,Esen Sefik,Jay S Stanley III,Boris Landa,Francesco Strino,Sarah Platt,James Garritano,Ian D Odell,Ronald Coifman,Richard A Flavell,Peggy Myung,Yuval Kluger

Journal

Nature Biotechnology

Published Date

2024/4/5

Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection

Natural killer (NK) cells are present in the circulation and can also be found residing in tissues, and these populations exhibit distinct developmental requirements and are thought to differ in terms of ontogeny. Here, we investigate whether circulating conventional NK (cNK) cells can develop into long-lived tissue-resident NK (trNK) cells following acute infections. We found that viral and bacterial infections of the skin triggered the recruitment of cNK cells and their differentiation into Tcf1hiCD69hi trNK cells that share transcriptional similarity with CD56brightTCF1hi NK cells in human tissues. Skin trNK cells arose from interferon (IFN)-γ-producing effector cells and required restricted expression of the transcriptional regulator Blimp1 to optimize Tcf1-dependent trNK cell formation. Upon secondary infection, trNK cells rapidly gained effector function and mediated an accelerated NK cell response. Thus, cNK cells …

Authors

Tommaso Torcellan,Christin Friedrich,Rémi Doucet-Ladevèze,Thomas Ossner,Virgínia Visaconill Solé,Sofie Riedmann,Milas Ugur,Fabian Imdahl,Stephan P Rosshart,Sebastian J Arnold,Mercedes Gomez de Agüero,Nicola Gagliani,Richard A Flavell,Simone Backes,Wolfgang Kastenmüller,Georg Gasteiger

Journal

Immunity

Published Date

2024/1/9

IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction

Background & AimsThe liver is one of the organs most commonly affected by metastasis. The presence of liver metastases has been reported to be responsible for an immunosuppressive microenvironment and diminished immunotherapy efficacy. Herein, we aimed to investigate the role of IL-10 in liver metastasis and to determine how its modulation could affect the efficacy of immunotherapy in vivo.MethodsTo induce spontaneous or forced liver metastasis in mice, murine cancer cells (MC38) or colon tumor organoids were injected into the cecum or the spleen, respectively. Mice with complete and cell type-specific deletion of IL-10 and IL-10 receptor alpha were used to identify the source and the target of IL-10 during metastasis formation. Programmed death ligand 1 (PD-L1)-deficient mice were used to test the role of this checkpoint. Flow cytometry was applied to characterize the regulation of PD-L1 by IL-10 …

Authors

Ahmad Mustafa Shiri,Tao Zhang,Tanja Bedke,Dimitra E Zazara,Lilan Zhao,Jöran Lücke,Morsal Sabihi,Antonella Fazio,Siwen Zhang,Daniele VF Tauriello,Eduard Batlle,Babett Steglich,Jan Kempski,Theodora Agalioti,Mikołaj Nawrocki,Yang Xu,Kristoffer Riecken,Imke Liebold,Leonie Brockmann,Leonie Konczalla,Lidia Bosurgi,Baris Mercanoglu,Philipp Seeger,Natalie Küsters,Panagis M Lykoudis,Asmus Heumann,Petra C Arck,Boris Fehse,Philipp Busch,Rainer Grotelüschen,Oliver Mann,Jakob R Izbicki,Thilo Hackert,Richard A Flavell,Nicola Gagliani,Anastasios D Giannou,Samuel Huber

Journal

Journal of Hepatology

Published Date

2024/4/1

Genetically modified non-human animals and methods of use thereof

FWBHETKCLVMNFS-UHFFFAOYSA-N 4', 6-Diamino-2-phenylindol Chemical compound C1= CC (C (= N) N)= CC= C1C1= CC2= CC= C (C (N)= N) C= C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1

Published Date

2023/6/14

A novel humanized mouse model recapitulates the unique TME found in patients with HIV-associated NSCLC

Among people with HIV (PWH), non-small cell lung cancer (NSCLC) is increasing in incidence, presents with more advanced disease, and portends a worse prognosis compared to the general NSCLC population. Despite effective control of viral replication with antiretroviral therapy (ART), PWH have evidence of immune dysfunction, and it is unknown whether these immune perturbations impact the tumor microenvironment (TME) to influence disease disparities.Here we preclinically model HIV-associated NSCLC using MISTRG6-A2, a humanized mouse system that is highly optimized for development of functional innate and adaptive immune cells. We compare tumor growth and immune features of HIV-infected, ART-suppressed MISTRG6-A2 hosts to uninfected hosts, with parameters informed by parallel analyses of human tissue samples obtained from PWH with NSCLC, and non-HIV controls.MISTRG6-A2 …

Authors

Melani Juric,Gabriel Kaufmann,Li Zhu,Kishu Ranjan,Kriti Agrawal,Barani Kumar Rajendran,Jyothi K Rajashekar,Hongyu Zhao,Yuval Kluger,Brinda Emu,Kurt A Schalper,Priti Kumar,Richard A Flavell,Michael Chiorazzi

Journal

Cancer Research

Published Date

2024/3/22

Professor FAQs

What is Richard A. Flavell's h-index at Yale University?

The h-index of Richard A. Flavell has been 132 since 2020 and 275 in total.

What are Richard A. Flavell's research interests?

The research interests of Richard A. Flavell are: Immunology

What is Richard A. Flavell's total number of citations?

Richard A. Flavell has 285,005 citations in total.

academic-engine

Useful Links